These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32806638)

  • 1. The Value of Targeting Complement Components in Asthma.
    Mohamed MME; Nicklin AD; Stover CM
    Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32806638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New concepts on the therapeutic control of complement anaphylatoxin receptors.
    Hawksworth OA; Li XX; Coulthard LG; Wolvetang EJ; Woodruff TM
    Mol Immunol; 2017 Sep; 89():36-43. PubMed ID: 28576324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade.
    Vitiello A; La Porta R; D'Aiuto V; Ferrara F
    Hum Immunol; 2021 Apr; 82(4):264-269. PubMed ID: 33632561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement in asthma: sensitivity to activation and generation of C3a and C5a via the different complement pathways.
    Wust SK; Blumenthal MN; Corazalla EO; Benson BA; Dalmasso AP
    Transl Res; 2006 Oct; 148(4):157-63. PubMed ID: 17002917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement components as potential therapeutic targets for asthma treatment.
    Khan MA; Nicolls MR; Surguladze B; Saadoun I
    Respir Med; 2014 Apr; 108(4):543-9. PubMed ID: 24468195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and function of anaphylatoxins and their receptors in allergic asthma.
    Laumonnier Y; Wiese AV; Figge J; Karsten C
    Mol Immunol; 2017 Apr; 84():51-56. PubMed ID: 27916272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma.
    Krug N; Tschernig T; Erpenbeck VJ; Hohlfeld JM; Köhl J
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1841-3. PubMed ID: 11734433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of complement in the diagnosis and management of allergic rhinitis and allergic asthma.
    Laumonnier Y; Schmudde I; Köhl J
    Curr Allergy Asthma Rep; 2011 Apr; 11(2):122-30. PubMed ID: 21170614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses.
    Nilsson PH; Thomas AM; Bergseth G; Gustavsen A; Volokhina EB; van den Heuvel LP; Barratt-Due A; Mollnes TE
    Mol Immunol; 2017 Sep; 89():111-114. PubMed ID: 28610663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food intake regulation by central complement system.
    Ohinata K; Yoshikawa M
    Adv Exp Med Biol; 2008; 632():35-46. PubMed ID: 19025112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats.
    Abe M; Shibata K; Akatsu H; Shimizu N; Sakata N; Katsuragi T; Okada H
    J Immunol; 2001 Oct; 167(8):4651-60. PubMed ID: 11591795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement mediators: key regulators of airway tissue remodeling in asthma.
    Khan MA; Assiri AM; Broering DC
    J Transl Med; 2015 Aug; 13():272. PubMed ID: 26289385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidosis activates complement system in vitro.
    Emeis M; Sonntag J; Willam C; Strauss E; Walka MM; Obladen M
    Mediators Inflamm; 1998; 7(6):417-20. PubMed ID: 9927235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperresponsiveness of granulocytes to anaphylatoxins, C5a and C3a, in Churg-Strauss syndrome.
    Tanaka T; Abe M; Mitsuyama T; Fukuoka Y; Sakurada T; Hara N
    Intern Med; 1995 Oct; 34(10):1005-8. PubMed ID: 8563079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylatoxins and infectious and non-infectious inflammatory diseases.
    Köhl J
    Mol Immunol; 2001 Aug; 38(2-3):175-87. PubMed ID: 11532279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer.
    Kleczko EK; Kwak JW; Schenk EL; Nemenoff RA
    Front Immunol; 2019; 10():954. PubMed ID: 31134065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome.
    Ruffatti A; Tonello M; Macor P; Calligaro A; Del Ross T; Favaro M; Lotti V; Carletto A; Hoxha A; Biasi D
    Blood; 2021 May; 137(21):2989-2992. PubMed ID: 33649771
    [No Abstract]   [Full Text] [Related]  

  • 18. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
    Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
    FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation during sepsis in humans.
    Schreiber H; Rittirsch D; Flierl M; Brueckner U; Schneider M; Weiss M; Gebhard F; Huber-Lang M
    Adv Exp Med Biol; 2006; 586():217-26. PubMed ID: 16893075
    [No Abstract]   [Full Text] [Related]  

  • 20. Anaphylatoxins: their role in bacterial infection and inflammation.
    Haas PJ; van Strijp J
    Immunol Res; 2007; 37(3):161-75. PubMed ID: 17873401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.